Baropharm Co.Ltd.
Latest round
- Series B
Last raised
- May 2023
Total raised
- $15M
Investors
- 6
About Baropharm Co.Ltd.
Ltd. operates an integrated drug order platform that enables pharmacists to search for and order medicines directly from wholesalers. The company was founded by Seulgi Kim., Ltd.Ltd. The company offers a wide portfolio of pharmaceutical products, including prescription drugs, over-the-counter medications, and healthcare supplements. It also offers an integrated drug platform that controls the wholesale sites utilized by existing pharmacies in one place, allowing enterprises to order pharmaceuticals from a single site rather than individually visiting various wholesale sites.
Who invested in Baropharm Co.Ltd.
6 investors across 3 rounds
See all investors in Baropharm Co.Ltd.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Baropharm Co.Ltd.
Who invested in Baropharm Co.Ltd.?
Baropharm Co.Ltd. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Baropharm Co.Ltd. raised?
Baropharm Co.Ltd. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Baropharm Co.Ltd. last raise money?
Baropharm Co.Ltd.'s most recent round on record is a Series B, in May 2023.
What does Baropharm Co.Ltd. do?
Baropharm Co.Ltd. is a internet company.
Where is Baropharm Co.Ltd. headquartered?
Baropharm Co.Ltd. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Baropharm Co.Ltd.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back internet companies at Baropharm Co.Ltd.'s stage. Their profiles are linked below.
VCs backing internet startups at Series B
Raising like Baropharm Co.Ltd.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.